N-Nitroso Methyl Flecainide Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Flecainide is used to prevent and treat abnormally rapid heart rates, including conditions such as paroxysmal supraventricular tachycardia (PSVTs), Wolff-Parkinson-White syndrome, atrioventricular nodal re-entrant tachycardia (AVNRT), AV re-entrant tachycardia (AVRT), and atrial fibrillation/atrial flutter in patients.N-Nitroso Methyl Flecainide Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Methyl Flecainide Impurity CAS NO:NA chemically represented as N-((4-Methyl-1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide.Synchemia is the leading manufacturing and exporter of N-Nitroso Methyl Flecainide Impurity . We supply N-Nitroso Methyl Flecainide Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142210 |
| CAS No | NA |
| Mol.F. | C17H18N4O |
| Mol.Wt. | 294.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142211 |
| CAS No | NA |
| Mol.F. | C18H20N4O2 |
| Mol.Wt. | 324.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142212 |
| CAS No | NA |
| Mol.F. | C18H18N4O3 |
| Mol.Wt. | 338.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142213 |
| CAS No | NA |
| Mol.F. | C19H22N4O3 |
| Mol.Wt. | 354.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142214 |
| CAS No | NA |
| Mol.F. | C19H18N4O3 |
| Mol.Wt. | 350.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142215 |
| CAS No | NA |
| Mol.F. | C17H20N4O2 |
| Mol.Wt. | 312.37 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142216 |
| CAS No | NA |
| Mol.F. | C7H15N3O3S |
| Mol.Wt. | 221.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142217 |
| CAS No | NA |
| Mol.F. | C16H23N3O3 |
| Mol.Wt. | 305.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142218 |
| CAS No | NA |
| Mol.F. | C18H27N7O3 |
| Mol.Wt. | 389.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142219 |
| CAS No | NA |
| Mol.F. | C9H17N3O3 |
| Mol.Wt. | 215.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142220 |
| CAS No | NA |
| Mol.F. | C19H26N6O5 |
| Mol.Wt. | 418.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142221 |
| CAS No | NA |
| Mol.F. | C24H29N9O5 |
| Mol.Wt. | 523.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142222 |
| CAS No | NA |
| Mol.F. | C18H24N6O5 |
| Mol.Wt. | 404.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142223 |
| CAS No | NA |
| Mol.F. | C28H38N10O5 |
| Mol.Wt. | 594.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142224 |
| CAS No | NA |
| Mol.F. | C11H13N5O3 |
| Mol.Wt. | 263.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142225 |
| CAS No | NA |
| Mol.F. | C18H20N6O5 |
| Mol.Wt. | 400.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |